Have a personal or library account? Click to login
A Narrative Review of the Lesser Known Medications for Treatment of Restless Legs Syndrome and Pathogenetic Implications for Their Use Cover

A Narrative Review of the Lesser Known Medications for Treatment of Restless Legs Syndrome and Pathogenetic Implications for Their Use

Tremor and Other Hyperkinetic Movements
Volume 13 (2023): Issue 1
By: Paul G. Yeh,  Karen Spruyt,  Lourdes M. DelRosso and  Arthur S. Walters  
Open Access
|Mar 2023

Authors

Paul G. Yeh

paul.yeh@utrgv.edu

College of Health Professions, University of Texas Rio Grande Valley, Edinburg, Texas; Postdoctoral Fellow, National Cancer Institute Cancer Control Research Training Program (T32/CA05771), University of Texas Health Science Center at Houston School of Public Health, Houston, Texas

Karen Spruyt

karen.spruyt@inserm.fr

Université de Paris, NeuroDiderot INSERM

Lourdes M. DelRosso

lourdesdelrosso@icloud.com

Pulmonary and Sleep Medicine, University of California San Francisco-Fresno, Fresno, California

Arthur S. Walters

art.walters@vumc.org

Department of Neurology, Sleep Division, Vanderbilt University Medical Center, Nashville, Tennessee
DOI: https://doi.org/10.5334/tohm.739 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Nov 20, 2022
Accepted on: Feb 11, 2023
Published on: Mar 2, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
clonidine,
dipyridamole,
perampanel,
amantadine,
ketamine,
carbamazepine,
oxcarbazepine,
lamotrigine,
topiramate,
valproic acid,
levetiracetam,
steroids,
cannabis,
bupropion

© 2023 Paul G. Yeh, Karen Spruyt, Lourdes M. DelRosso, Arthur S. Walters, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 13 (2023): Issue 1Next article